Exposure of nursing mothers to polycyclic aromatic hydrocarbons: Levels of un-metabolized and metabolized compounds in breast milk, major sources of exposure and infants' health risks.

Biomarkers of exposure Human biomonitoring Infant exposure assessment PAH metabolites (OH-PAHs) Polycyclic aromatic hydrocarbons (PAHs)

Journal

Environmental pollution (Barking, Essex : 1987)
ISSN: 1873-6424
Titre abrégé: Environ Pollut
Pays: England
ID NLM: 8804476

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 19 05 2020
revised: 10 07 2020
accepted: 10 07 2020
pubmed: 24 7 2020
medline: 17 9 2020
entrez: 24 7 2020
Statut: ppublish

Résumé

In this study, biomonitoring of nursing Portuguese mothers to polycyclic aromatic hydrocarbons (PAHs) exposure and assessment of potential health risks of their infants were performed through determination of 18 PAHs and 6 major metabolites (OH-PAHs) in breast milk. Concentrations of total PAHs ranged between 55.2 and 1119 ng/g fat, being naphthalene, dibenz(a,h)anthracene, benzo(g,h,i)perylene, and phenanthrene the most abundant compounds (68.4% of ∑PAHs). Benzo(a)pyrene, known carcinogenic, was not detected. Total levels of OH-PAHs ranged from 6.66 to 455 ng/g fat with 1-hydroxyphenanthrene, 1-hydroxynaphthalene and 1-hydroxyacenaphthene as major compounds (96% of ∑OH-PAHs). Concentrations of ∑PAHs and ∑OH-PAHs were strongly correlated between each other (r = 0.692; p ≤ 0.001) and moderately-to-strongly associated with individual compounds (0.203 < r < 0.841; p ≤ 0.001). The attained data suggest increased levels of PAHs in older nursing mothers (>30 years) and in those whose child had lower weight (up to 3.0 kg). Breast-fed infant presented a median PAHs daily intake of 1.41 μg/kg body weight (total benzo(a)pyrene equivalents of 0.0679 μg/kg) and were exposed to 0.024 μg/kg body weight of ∑PAH4 [benz(a)anthracene, benzo(b)fluoranthene, benzo(j)fluoranthene, and chrysene]. Although breast milk is a secure food for newborns, un-metabolized and metabolized PAHs should be included in biomonitoring surveillance studies during breastfeeding to prevent potential health risks for infants.

Identifiants

pubmed: 32702605
pii: S0269-7491(20)33704-0
doi: 10.1016/j.envpol.2020.115243
pii:
doi:

Substances chimiques

Polycyclic Aromatic Hydrocarbons 0
Benzo(a)pyrene 3417WMA06D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115243

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that there are no conflicts of interest. This work has received approval for research ethics from the Ethics Committee of University School Vasco da Gama (Coimbra, Portugal) and a proof/certificate of approval is available upon request.

Auteurs

Marta Oliveira (M)

REQUIMTE-LAQV, Instituto Superior de Engenharia, Rua Dr. António Bernardino de Almeida 431, 4249-015 Porto, Portugal.

Sofia Duarte (S)

REQUIMTE-LAQV, Laboratório de Bromatologia e Farmacognosia, Faculdade de Farmácia, Universidade de Coimbra, Polo Das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; Centro de Investigação Vasco da Gama, Escola Universitária Vasco da Gama, Avenida José R. Sousa Fernandes, Campus Universitário, Lordemão, 3020-210 Coimbra, Portugal.

Cristina Delerue-Matos (C)

REQUIMTE-LAQV, Instituto Superior de Engenharia, Rua Dr. António Bernardino de Almeida 431, 4249-015 Porto, Portugal.

Angelina Pena (A)

REQUIMTE-LAQV, Laboratório de Bromatologia e Farmacognosia, Faculdade de Farmácia, Universidade de Coimbra, Polo Das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.

Simone Morais (S)

REQUIMTE-LAQV, Instituto Superior de Engenharia, Rua Dr. António Bernardino de Almeida 431, 4249-015 Porto, Portugal. Electronic address: sbm@isep.ipp.pt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH